Effect of a Phosphodiesterase 5 Inhibitor on Pulmonary and Cerebral Arteries of Newborn Piglets with Chronic Hypoxia-Induced Pulmonary Hypertension
Author(s) -
Candice D. Fike,
Mark R. Kaplowitz,
Yongmei Zhang,
Mark W. Dantuma,
Jane A. Madden
Publication year - 2011
Publication title -
neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.399
H-Index - 84
eISSN - 1661-7819
pISSN - 1661-7800
DOI - 10.1159/000326270
Subject(s) - zaprinast , medicine , pulmonary hypertension , hypoxia (environmental) , cerebral arteries , cerebral circulation , pulmonary artery , anesthesia , middle cerebral artery , cardiology , nitric oxide , ischemia , chemistry , organic chemistry , oxygen , guanylate cyclase
The use of phosphodiesterase 5 (PDE5) inhibitors to treat newborns with pulmonary hypertension is increasing. The effect of PDE5 inhibitors on the neonatal cerebral circulation remains unknown. The neonatal piglet model of chronic hypoxia-induced pulmonary hypertension allows the study of the effects of PDE5 inhibitors on both the pulmonary and cerebral circulations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom